These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. A Renal-Clearable Activatable Molecular Probe for Fluoro-Photacoustic and Radioactive Imaging of Cancer Biomarkers. Li S; Li Q; Chen W; Song Z; An Y; Chen P; Wu Y; Wang G; He Y; Miao Q Small; 2022 Jul; 18(28):e2201334. PubMed ID: 35723177 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer. Harada N; Kimura H; Onoe S; Watanabe H; Matsuoka D; Arimitsu K; Ono M; Saji H J Nucl Med; 2016 Dec; 57(12):1978-1984. PubMed ID: 27417647 [TBL] [Abstract][Full Text] [Related]
14. A PSMA Ligand Labeled with Cobalt-55 for PET Imaging of Prostate Cancer. Dam JH; Olsen BB; Baun C; Høilund-Carlsen PF; Thisgaard H Mol Imaging Biol; 2017 Dec; 19(6):915-922. PubMed ID: 28924629 [TBL] [Abstract][Full Text] [Related]
15. Lee BS; Chu SY; Jung WJ; Jeong HJ; Lee K; Kim MH; Kim MH; Chi DY; Ahn H; Lee YJ; Lee KC; Lim SM Prostate; 2020 Dec; 80(16):1383-1393. PubMed ID: 32960990 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide- Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625 [TBL] [Abstract][Full Text] [Related]
17. PSMA-targeted melanin-like nanoparticles as a multifunctional nanoplatform for prostate cancer theranostics. Dai L; Shen G; Wang Y; Yang P; Wang H; Liu Z J Mater Chem B; 2021 Jan; 9(4):1151-1161. PubMed ID: 33434248 [TBL] [Abstract][Full Text] [Related]
18. Dual contrast agents for fluorescence and photoacoustic imaging: evaluation in a murine model of prostate cancer. Lesniak WG; Wu Y; Kang J; Boinapally S; Ray Banerjee S; Lisok A; Jablonska A; Boctor EM; Pomper MG Nanoscale; 2021 May; 13(20):9217-9228. PubMed ID: 33978042 [TBL] [Abstract][Full Text] [Related]
19. Targeting Prostate-Specific Membrane Antigen (PSMA) with F-18-Labeled Compounds: the Influence of Prosthetic Groups on Tumor Uptake and Clearance Profile. Bouvet V; Wuest M; Bailey JJ; Bergman C; Janzen N; Valliant JF; Wuest F Mol Imaging Biol; 2017 Dec; 19(6):923-932. PubMed ID: 28639122 [TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer. Eder M; Schäfer M; Bauder-Wüst U; Haberkorn U; Eisenhut M; Kopka K Prostate; 2014 May; 74(6):659-68. PubMed ID: 24464532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]